Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Anticancer Agents Med Chem ; 17(2): 250-264, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27745548

RESUMO

Enzymatic activity from tumor and adjacent normal tissue of 200 patients involving deoxycytidine kinase (dCK), uridine/cytidine kinase (U/CK), cytidine deaminase (CD) and deoxycytidylate deaminase (dCMPD) was quantified. Patients with brain (17), colon (24), and breast (30) tumors, 53, 67, and 73%, respectively, had an elevated T/N value (Specific Activity of tumor/ Specific Activity of normal tissue) involving dCK and dCMPD suggesting chemotherapy with 5-fluorodeoxycytidine (5-FdC) alone or in combination with thymidine plus deoxytetrahydrouridine, or with the radiosensitizer, 5-chlorodeoxycytidine (5-CldC) plus tetrahydrouridine (H4U). Among patients with colon (19) and pancreatic tumors (40), 53 and 68 %, respectively, displayed T/N values >4 for CD suggesting chemotherapy with 5-FdC, 4-N-methylamino-5-FdC, 5-trifluoromethyldeoxycytidine and radiosensitization with 5- CldC, 4-N-methylamino-5-CldC, 5-iododeoxycytidine and 5-bromodeoxycytidine. The percent of patients with tumors with a T/N value >4 for U/CK in lung (72), colon (23) and breast (28) was 47, 61 and 68, respectively, suggesting zebularine (plus thymidine) treatment for tumors involving gene silencing. Evidence is presented that the 4-N-alkylamino-dC substituted nucleosides and those with large 5-substitutions are activated only via CD to thymidine kinase (TK) using end-points of cytotoxicity and/or radiosensitization: H4U, the inhibitor of CD is an antagonist, cells with low CD or no TK are resistant to the analogs, the end points are indifferent to the dCK status of cells, they are poor substrates for dCK and good substrates for CD, whereas 5-FdC and 5-CldC are good substrates for both enzymes. The analogs present opportunities for Collateral Sensitivity for 5-azacytidine and gemcitabine resistant tumors.


Assuntos
Antineoplásicos/uso terapêutico , Neoplasias/tratamento farmacológico , Neoplasias/radioterapia , Nucleosídeos de Pirimidina/uso terapêutico , Antineoplásicos/química , Linhagem Celular Tumoral , Citidina Desaminase/metabolismo , DCMP Desaminase/metabolismo , Desoxicitidina Quinase/metabolismo , Humanos , Neoplasias/enzimologia , Nucleosídeos de Pirimidina/química , Radiossensibilizantes/química , Radiossensibilizantes/uso terapêutico , Uridina Quinase/metabolismo
2.
Crim Behav Ment Health ; 20(1): 62-71, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20104475

RESUMO

BACKGROUND: Changes in mental health service provision in most western countries have been associated with an increasing role of the police in the community management of people with mental health problems, but little is known about how the police perceive this in the UK. OBJECTIVES: To investigate police officers' views on their roles in dealings with people with mental health problems and with mental health services. METHODS: Nine in-depth semi-structured interviews were conducted with front line police officers. These interviews were analysed for recurrent themes using interpretative phenomenological analysis. RESULTS: The recurrent themes identified were: emotional aspects of dealing with people with mental health problems and with services, impact of incidents on police resources and on people with mental health problems, success through collaborative working with health services and failure in its absence. CONCLUSIONS: Police officers' experiences of work with people with mental disorder in the community in Scotland had much in common with those previously reported in the USA and in Australia. Development of more collaborative approaches and mutual respect between the police and mental health service providers would resolve many of the currently perceived difficulties.


Assuntos
Atitude Frente a Saúde , Transtornos Mentais/psicologia , Serviços de Saúde Mental , Polícia , Tomada de Decisões , Feminino , Humanos , Entrevistas como Assunto , Masculino , Saúde Mental , Escócia , Percepção Social , População Urbana
3.
Int J Chron Obstruct Pulmon Dis ; 1(2): 189-99, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-18046896

RESUMO

Chronic lipopolysaccharide (LPS) exposure may contribute to the pathogenesis of a number of lung diseases including COPD and emphysema. We sought to develop a large-animal model of emphysema using repeated LPS administration into sheep lung segments. An experimental protocol was designed to facilitate comparisons with elastase-treated and control segments within the same lung of individual sheep. Histopathologic evaluation of segments treated with LPS demonstrated low-grade inflammation characterized by an increase in the number of intra-alveolar macrophages and lymphocytes. Treated segments demonstrated a significant reduction in airspace surface area (ASA), an increase in percent disrupted alveolar attachments and the distance between normal alveolar attachments, and a reduction in the number of normal alveolar attachments surrounding nonrespiratory bronchioles. Coefficient of variation of individual ASA measurements in elastase-treated segments was indicative of a heterogeneous parenchymal response, in contrast to that associated with chronic LPS treatment. Our results demonstrate that chronic LPS treatment of individual lung segments in sheep induces microscopic emphysema qualitatively and quantitatively consistent with both accepted pathologic definitions of this condition and with that produced by airway instillation of elastolytic enzymes. Development of this phenotype is associated with evidence of downregulated activation of transforming growth factor beta.


Assuntos
Modelos Animais de Doenças , Enfisema , Lipopolissacarídeos/administração & dosagem , Elastase Pancreática/administração & dosagem , Animais , Brônquios , Líquido da Lavagem Broncoalveolar , Instilação de Medicamentos , Ovinos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...